Stable pRNA Three-Way Junctions for Therapeutic Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
RNA nanomotifs, such as pRNA 3WJs, face challenges due to their low stability, which hinders their application in diagnostics and therapeutics, requiring more stable constructs for therapeutic delivery and disease diagnosis.
Innovation Solution
Development of novel trifurcate pRNA 3WJ motifs with enhanced stability, achieved through specific deletions and metal ion effects, which contribute to improved self-assembly properties and thermodynamic stability, making them suitable for therapeutic and biotechnology applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If traditional pRNA 3WJ motifs are used, then they can be assembled from three single RNA oligonucleotide strands, but they exhibit low thermodynamic stability
Solution Approach 1:
The patent applies parameter changes by modifying the nucleotide sequences of the RNA oligonucleotides to optimize base pairing interactions. Specifically, the invention adjusts the sequence parameters of strands 3WJa, 3WJb, and 3WJc to enhance the thermodynamic stability of the three-way junction while maintaining the ability to self-assemble. This includes optimizing the helical regions and junction structure to achieve more favorable free energy values.
Solution Approach 2:
The patent employs composite material principles by designing a three-component RNA system where multiple oligonucleotide strands with different sequences work together. The composite structure consists of three distinct RNA strands (3WJa, 3WJb, 3WJc) that self-assemble through complementary base pairing to form a stable three-way junction, leveraging the synergistic interactions between different sequence components.
2Stability of the object's composition
If pRNA 3WJ motifs are designed for therapeutic delivery, then they need enhanced stability, but this increases the complexity of construct design
Solution Approach 1:
The patent applies segmentation by dividing the pRNA 3WJ construct into three separate oligonucleotide strands (3WJa, 3WJb, 3WJc), each with specific functional regions. This segmentation allows independent optimization of each strand's sequence for stability while maintaining modular assembly, reducing the overall design complexity compared to designing a single complex strand.
Solution Approach 2:
The patent implements universality by creating a standardized three-way junction platform that can serve multiple therapeutic applications. The core 3WJ structure with enhanced stability serves as a universal scaffold that can be adapted for different therapeutic delivery needs, reducing design complexity through reuse of the stabilized core structure across different applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel pRNA 3WJ motifs demonstrate increased thermodynamic stability and self-assembly capabilities, offering improved stability and functionality for therapeutic delivery and biotechnology applications compared to traditional scaffolds.
Implementation Method 1
metal ion effects, which contribute to improved self-assembly properties and thermodynamic stability
Implementation Method 2
The 3WJ can be assembled from three single RNA oligonucleotide strands (denoted 3WJa, 3WJb, and 3WJc) mixed in approximately equimolar concentrations
Implementation Method 3
the phi29 bacteriophage pRNA 3WJ nanomotif... successfully used as a building block in the rational design of nanostructures... which base pair according to Watson-Crick base pairing
Data Source
AI summary
Three-way junction (3WJ) RNA scaffolds derived from phi29, M2, SF5, and GA1 pRNAs and which have high stability are described. The pRNA 3WJ scaffolds can be used to form compounds, conjugates, compositions, and nanoparticles for delivery of active agents for therapeutic and/or diagnostic functions.